Bio-Skin

Welcome To Bio-Skin

Here at LyfeTec, our Bio-Skin product line is beginning its first stage of new clinical trial and testing with the new additives for anti-aging and skin cell rejuvenation for the US. We are preparing to perform Phase I and Phase II safety and efficacy trials for pharmaceuticals as well as cosmetic and nutraceutical testing.

Safety Trials

Bio-Skin will initiate a wide range of safety tests required for FDA approval. LyfeTec will be launching Bio-Skin as a lotion to generate revenues for our products. In addition, we will be conducting trials for and with evaluating systemic safety (e.g. ECGs, clinical chemical parameters) and histological / immunohistochemical effects.

Routine in-house efficacy trials include:

Psoriasis, plaque test
UV-induced erythema model (for anti-inflammatories)
Vasoconstrictor assay (corticosteroids)
Proof-of-concept trials

Cradle Cap
Acne
Psoriasis
Atopic Dermatitis
Androgenetic Alopecia
Onychomycosis
Melanoma and more...

Anti-aging
UVA protection

Proof-of-Concept Trials

Dr. Klingelhoeller’s core expertise as the company's Chief Biotech Chemist for the Bio-Skin product line has development, clinical trials and documentation on a similar product. The Bio-Skin products are a new and improved formula for anti-aging and skin cancer treatments. In these models, biophysical measurement methods are used to deliver objective data to support traditional clinical endpoints.

Dr. Klingelhoeller’s Previous Regividerm Trials

Home | About | Trial Results | Contact